CD134 (OX40), Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD134 (OX40), Mouse antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD134 (OX40), Mouse |
| Clone | REA625 |
| Host Species | Recombinant Human |
| Reactive Species | mouse |
| Isotype | IgG1 |
| Format | biotin conjugate |
| Size | 30 µg in 1 mL |
| Concentration | 1:10 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD134 (OX40) Antibody, anti-mouse, Biotin, REAfinity™. Clone REA625 recognizes the CD134 antigen, also known as OX40 receptor, a 50 kDa type I membrane glycoprotein of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. OX40 is a secondary costimulatory molecule, which is expressed after 24 to 72 hours following activation. It is expressed on activated mouse T cells and B cells. The OX40 receptor binds to the OX40 ligand (CD252) to provide a costimulatory signal which is independent of CD28. | Additional information: Clone REA625 displays negligible binding to Fc receptors. | |
| Immunogen | n/a |
| Other Names | OX40L receptor, OX-40, TNFRSF4 |
| Gene, Accession # | Gene ID: 22163 |
| Catalog # | 130-111-582 |
| Price | $57 |
| Order / More Info | CD134 (OX40), Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Akiba, H. et al. (1999) CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol 162 (12): 7058-7066. | Kjaergaard, J. et al. (2001) Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. J Immunol 167: 6669-6677. | al-Shamkhani, A. et al. (1996) OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur. J. Immunol. 26 (8): 1695-1699. | Hong, G. U. et al. (2015) IgE and IgA produced by OX40-OX40L or CD40-CD40L interaction in B cells-mast cells re-activate FcεRI or FcαRI on mast cells in mouse allergic asthma. Eur. J. Pharmacol. 754: 199-210. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies